Cargando…

Editorial: Human Tumor-Derived p53 Mutants: A Growing Family of Oncoproteins

Detalles Bibliográficos
Autores principales:	Haupt, Ygal, Blandino, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940365/ https://www.ncbi.nlm.nih.gov/pubmed/27462578 http://dx.doi.org/10.3389/fonc.2016.00170

Ejemplares similares

Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways
por: Haupt, Sue, et al.
Publicado: (2016)

Regulation of Mutant p53 Protein Expression
por: Vijayakumaran, Reshma, et al.
Publicado: (2015)

p53 Calls upon CIA (Calcium Induced Apoptosis) to Counter Stress
por: Haupt, Sue, et al.
Publicado: (2015)

Gender, mutant p53 and PML: A growing “affaire” in tumor suppression and oncogenesis
por: Di Agostino, Silvia, et al.
Publicado: (2013)

Oncogenic Intra-p53 Family Member Interactions in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2016)

Editorial: Mutant p53 in Cancer Progression and Personalized Therapeutic Treatments
por: Timofeev, Oleg
Publicado: (2021)

Editorial: Overcoming the cell membrane to target intracellular oncoproteins
por: Brown, Christopher J., et al.
Publicado: (2023)

P53 at the start of the 21st century: lessons from elephants
por: Haupt, Sue, et al.
Publicado: (2017)

Cancer and Tumour Suppressor p53 Encounters at the Juncture of Sex Disparity
por: Haupt, Sue, et al.
Publicado: (2021)

New therapeutic strategies to treat human cancers expressing mutant p53 proteins
por: Blandino, Giovanni, et al.
Publicado: (2018)

Amplifying Tumor–Stroma Communication: An Emerging Oncogenic Function of Mutant p53
por: Capaci, Valeria, et al.
Publicado: (2021)

MYCN: from oncoprotein to tumor-associated antigen
por: Pistoia, Vito, et al.
Publicado: (2012)

Editorial: Roles of non-coding RNAs in tumor growth and development
por: Sharma, Gunjan, et al.
Publicado: (2022)

Targeting mutant p53 in cancer: the latest insights
por: Di Agostino, Silvia, et al.
Publicado: (2019)

Targeting Oncogenic Mutant p53 for Cancer Therapy
por: Parrales, Alejandro, et al.
Publicado: (2015)

Mutant p53 in Cancer Progression and Targeted Therapies
por: Zhu, Gaoyang, et al.
Publicado: (2020)

Mutant p53 as a Regulator and Target of Autophagy
por: Shi, Yong, et al.
Publicado: (2021)

Oncogenomic Approaches in Exploring Gain of Function of Mutant p53
por: Donzelli, Sara, et al.
Publicado: (2008)

Alterations in Mitochondrial and Endoplasmic Reticulum Signaling by p53 Mutants
por: Giorgi, Carlotta, et al.
Publicado: (2016)

Mutant p53 and ETS2, a Tale of Reciprocity
por: Martinez, Luis Alfonso
Publicado: (2016)

Mutant p53: One, No One, and One Hundred Thousand
por: Walerych, Dawid, et al.
Publicado: (2015)

The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
por: Sabapathy, Kanaga
Publicado: (2015)

New Strategies to Direct Therapeutic Targeting of PML to Treat Cancers
por: Wolyniec, Kamil, et al.
Publicado: (2013)

Mutant p53 Protein and the Hippo Transducers YAP and TAZ: A Critical Oncogenic Node in Human Cancers
por: Ferraiuolo, Maria, et al.
Publicado: (2017)

microRNAs: short non-coding bullets of gain of function mutant p53 proteins
por: Donzelli, Sara, et al.
Publicado: (2014)

Mutant p53: Multiple Mechanisms Define Biologic Activity in Cancer
por: Kim, Michael Paul, et al.
Publicado: (2015)

Corrigendum: The Contrived Mutant p53 Oncogene – Beyond Loss of Functions
por: Sabapathy, Kanaga
Publicado: (2021)

Synergistic Rescue of Nonsense Mutant Tumor Suppressor p53 by Combination Treatment with Aminoglycosides and Mdm2 Inhibitors
por: Zhang, Meiqiongzi, et al.
Publicado: (2018)

Targeting mutant p53-R248W reactivates WT p53 function and alters the onco-metabolic profile
por: Brown, Kate, et al.
Publicado: (2023)

Regulation of Nucleotide Metabolism by Mutant p53 Contributes to its Gain-of-Function Activities
por: Kollareddy, Madhusudhan, et al.
Publicado: (2015)

P53: A Guardian of Immunity Becomes Its Saboteur through Mutation
por: Agupitan, Arjelle Decasa, et al.
Publicado: (2020)

Dysregulated Phosphorylation of p53, Autophagy and Stemness Attributes the Mutant p53 Harboring Colon Cancer Cells Impaired Sensitivity to Oxaliplatin
por: Therachiyil, Lubna, et al.
Publicado: (2020)

Beyond the Mevalonate Pathway: Control of Post-Prenylation Processing by Mutant p53
por: Borini Etichetti, Carla M, et al.
Publicado: (2020)

Clinical Overview of MDM2/X-Targeted Therapies
por: Burgess, Andrew, et al.
Publicado: (2016)

p53 Family and Cellular Stress Responses in Cancer
por: Pflaum, Johanna, et al.
Publicado: (2014)

Anticancer effect of Indanone-based thiazolyl hydrazone derivative on p53 mutant colorectal cancer cell lines: An in vitro and in vivo study
por: Narayanan, Silpa, et al.
Publicado: (2022)

Key Players in the Mutant p53 Team: Small Molecules, Gene Editing, Immunotherapy
por: Chasov, Vitaly, et al.
Publicado: (2020)

Inhibiting the system x(C)(−)/glutathione axis selectively targets cancers with mutant-p53 accumulation
por: Liu, David S., et al.
Publicado: (2017)

Proteasomal Degradation of p53 by Human Papillomavirus E6 Oncoprotein Relies on the Structural Integrity of p53 Core Domain
por: Bernard, Xavier, et al.
Publicado: (2011)

The Gain-of-Function p53 R248W Mutant Promotes Migration by STAT3 Deregulation in Human Pancreatic Cancer Cells
por: Klemke, Luisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9j36kt2cmmscj7osllakgs77f8